A CD6-targeted antibody conjugate (CD6-ADC) selectively ablates alloreactive proliferating T cells in humans and non-human primates (NHPs)
Research Grant
Administered By
Surgery
Awarded By
Massachusetts General Hospital
Start Date
November 1, 2024
End Date
October 31, 2027
Administered By
Surgery
Awarded By
Massachusetts General Hospital
Start Date
November 1, 2024
End Date
October 31, 2027